$113.99 USD
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 2nd Edition builds on the same foundation of clearly explained, up-to-date, and clinically current content as the trusted Lehne undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically need for safe and effective prescribing. Three introductory chapters provide foundational content for new prescribers in the areas of prescriptive authority, rational drug selection, prescription writing, and promoting positive outcomes of drug therapy. Core drug chapters are focused on the drugs that prescribers will most commonly see in clinical practice. A sharp focus is also placed on pharmacotherapeutic decision-making, with Black Box Warnings and new bulleted Key Prescribing Considerations features. The second edition features completely new chapters on Genetic and Genomic Considerations, Muscarinic Antagonists and Immunomodulators, and updated content throughout. It’s everything advanced practice nursing and Physician Assistant students need to be safe and effective prescribers!

  • Introductory chapters tailored to the specific needs of prescribers cover topics such as prescriptive authority, rational drug selection and prescription writing, and promoting positive outcomes of drug therapy.
  • Carefully focused pharmacotherapeutic content reflects the drugs most commonly seen and used by prescribers, with emphasis not on the first drug discovered or developed in each class but on the agents most often used today. Primary care drugs are addressed first in each chapter as appropriate, followed by acute care drugs.
  • UNIQUE! Prescriber-focused pedagogical aids further reinforce the most important information for prescribers.
  • Integrated coverage of Canadian trade names appears throughout the text and is highlighted with a familiar maple-leaf icon.
  • Integrated coverage of interprofessional collaboration addresses the growing global interest in interprofessional collaboration and incorporates opportunities for interprofessional collaborative practice throughout.

1. 18 : Introduction to Central Nervous System Pharmacology - p. 123 2. 19 : Drugs for Parkinson Disease - p. 126 3. 20 : Drugs for Alzheimer Disease - p. 142 4. 21 : Drugs for Seizure Disorders - p. 149 5. 22 : Drugs for Muscle Spasm and Spasticity - p. 170 6. 23 : Local Anesthetics - p. 177 7. 24 : Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics - p. 182 8. 25 : Drugs for Headache - p. 194 9. 26 : Antipsychotic Agents and Their Use in Schizophrenia - p. 201 10. 27 : Antidepressants - p. 213 11. 28 : Drugs for Bipolar Disorder - p. 227 12. 29 : Sedative-Hypnotic Drugs - p. 233 13. 30 : Management of Anxiety Disorders - p. 242 14. 31 : Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder - p. 247 15. 32 : Substance Use Disorders I: Basic Considerations - p. 253 16. 33 : Substance Use Disorders II: Alcohol - p. 259 17. 34 : Substance Use Disorders III: Nicotine and Smoking - p. 266 18. 35 : Substance Use Disorders IV: Major Drugs of Abuse Other Than Alcohol and Nicotine - p. 272 19. 36 : Review of Hemodynamics - p. 283 20. 37 : Diuretics - p. 289 21. 38 : Drugs Acting on the Renin-Angiotensin-Aldosterone System - p. 296 22. 39 : Calcium Channel Blockers - p. 307 23. 40 : Vasodilators - p. 312 24. 41 : Drugs for Hypertension - p. 315 25. 42 : Drugs for Heart Failure - p. 324 26. 43 : Antidysrhythmic Drugs - p. 336 27. 44 : Prophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels - p. 348 28. 45 : Drugs for Angina Pectoris - p. 363 29. 46 : Anticoagulant and Antiplatelet Drugs - p. 371 30. 47 : Drugs for Deficiency Anemias - p. 388 31. 48 : Drugs for Diabetes Mellitus - p. 396 32. 49 : Drugs for Thyroid Disorders - p. 415 33. 50 : Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications - p. 423 34. 51 : Birth Control - p. 436 35. 52 : Androgens - p. 446 36. 53 : Male Sexual Dysfunction and Benign Prostatic Hyperplasia - p. 453 37. 54 : Review of the Immune System - p. 466 38. 55 : Childhood Immunization - p. 475 39. 56 : Antihistamines - p. 487 40. 57 : Cyclooxygenase Inhibitors: Nonsteroidal Antiinflammatory Drugs and Acetaminophen - p. 492 41. 58 : Glucocorticoids in Nonendocrine Disorders - p. 503 42. 59 : Drug Therapy of Rheumatoid Arthritis - p. 511 43. 60 : Drug Therapy for Gout - p. 527 44. 61 : Drugs Affecting Calcium Levels and Bone Mineralization - p. 536 45. 62 : Drugs for Asthma and Chronic Obstructive Pulmonary Disease - p. 555 46. 63 : Drugs for Allergic Rhinitis, Cough, and Colds - p. 579 47. 64 : Drugs for Peptic Ulcer Disease - p. 587 48. 65 : Laxatives - p. 597 49. 66 : Other Gastrointestinal Drugs - p. 604 50. 67 : Vitamins - p. 615 51. 68 : Drugs for Weight Loss - p. 626 52. 69 : Complementary and Alternative Therapy - p. 634 53. 70 : Basic Principles of Antimicrobial Therapy - p. 649 54. 71 : Drugs That Weaken the Bacterial Cell Wall I: Penicillins - p. 661 55. 72 : Drugs That Weaken the Bacterial Cell Wall II: Other Drugs - p. 668 56. 73 : Bacteriostatic Inhibitors of Protein Synthesis - p. 675 57. 74 : Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis - p. 682 58. 75 : Sulfonamide Antibiotics and Trimethoprim - p. 687 59. 76 : Drug Therapy of Urinary Tract Infections - p. 694 60. 77 : Drug Therapy for Tuberculosis - p. 699 61. 78 : Miscellaneous Antibacterial Drugs - p. 710 62. 79 : Antifungal Agents - p. 714 63. 80 : Antiviral Agents I: Drugs for Non-HIV Viral Infections - p. 722 64. 81 : Antiviral Agents II: Drugs for HIV Infection - p. 743 65. 82 : Drug Therapy for Sexually Transmitted Diseases - p. 762 66. 83 : Anthelmintics - p. 770 67. 84 : Introduction to Immunomodulators - p. 775 68. 85 : Anticancer Drugs for the Nonspecialist - p. 780 69. 86 : Pain Management in Patients With Cancer - p. 813 70. 87 : Drugs for the Eye - p. 821 71. 88 : Drugs for the Skin - p. 833 72. 89 : Drugs for the Ear - p. 848 73. 90 : Agents Affecting the Volume and Ion Content of Body Fluids - p. 855 74. 91 : Management of ST-Segment Elevation Myocardial Infarction - p. 860 75. 92 : Drugs for Acute Care - p. 865 76. Appendix A : Canadian Drug Information - p. 875 77. Index - p. 879

Descripcion
Descripción

Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 2nd Edition builds on the same foundation of clearly explained, up-to-date, and clinically current content as the trusted Lehne undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically need for safe and effective prescribing. Three introductory chapters provide foundational content for new prescribers in the areas of prescriptive authority, rational drug selection, prescription writing, and promoting positive outcomes of drug therapy. Core drug chapters are focused on the drugs that prescribers will most commonly see in clinical practice. A sharp focus is also placed on pharmacotherapeutic decision-making, with Black Box Warnings and new bulleted Key Prescribing Considerations features. The second edition features completely new chapters on Genetic and Genomic Considerations, Muscarinic Antagonists and Immunomodulators, and updated content throughout. It’s everything advanced practice nursing and Physician Assistant students need to be safe and effective prescribers!

  • Introductory chapters tailored to the specific needs of prescribers cover topics such as prescriptive authority, rational drug selection and prescription writing, and promoting positive outcomes of drug therapy.
  • Carefully focused pharmacotherapeutic content reflects the drugs most commonly seen and used by prescribers, with emphasis not on the first drug discovered or developed in each class but on the agents most often used today. Primary care drugs are addressed first in each chapter as appropriate, followed by acute care drugs.
  • UNIQUE! Prescriber-focused pedagogical aids further reinforce the most important information for prescribers.
  • Integrated coverage of Canadian trade names appears throughout the text and is highlighted with a familiar maple-leaf icon.
  • Integrated coverage of interprofessional collaboration addresses the growing global interest in interprofessional collaboration and incorporates opportunities for interprofessional collaborative practice throughout.

1. 18 : Introduction to Central Nervous System Pharmacology - p. 123 2. 19 : Drugs for Parkinson Disease - p. 126 3. 20 : Drugs for Alzheimer Disease - p. 142 4. 21 : Drugs for Seizure Disorders - p. 149 5. 22 : Drugs for Muscle Spasm and Spasticity - p. 170 6. 23 : Local Anesthetics - p. 177 7. 24 : Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics - p. 182 8. 25 : Drugs for Headache - p. 194 9. 26 : Antipsychotic Agents and Their Use in Schizophrenia - p. 201 10. 27 : Antidepressants - p. 213 11. 28 : Drugs for Bipolar Disorder - p. 227 12. 29 : Sedative-Hypnotic Drugs - p. 233 13. 30 : Management of Anxiety Disorders - p. 242 14. 31 : Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder - p. 247 15. 32 : Substance Use Disorders I: Basic Considerations - p. 253 16. 33 : Substance Use Disorders II: Alcohol - p. 259 17. 34 : Substance Use Disorders III: Nicotine and Smoking - p. 266 18. 35 : Substance Use Disorders IV: Major Drugs of Abuse Other Than Alcohol and Nicotine - p. 272 19. 36 : Review of Hemodynamics - p. 283 20. 37 : Diuretics - p. 289 21. 38 : Drugs Acting on the Renin-Angiotensin-Aldosterone System - p. 296 22. 39 : Calcium Channel Blockers - p. 307 23. 40 : Vasodilators - p. 312 24. 41 : Drugs for Hypertension - p. 315 25. 42 : Drugs for Heart Failure - p. 324 26. 43 : Antidysrhythmic Drugs - p. 336 27. 44 : Prophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels - p. 348 28. 45 : Drugs for Angina Pectoris - p. 363 29. 46 : Anticoagulant and Antiplatelet Drugs - p. 371 30. 47 : Drugs for Deficiency Anemias - p. 388 31. 48 : Drugs for Diabetes Mellitus - p. 396 32. 49 : Drugs for Thyroid Disorders - p. 415 33. 50 : Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications - p. 423 34. 51 : Birth Control - p. 436 35. 52 : Androgens - p. 446 36. 53 : Male Sexual Dysfunction and Benign Prostatic Hyperplasia - p. 453 37. 54 : Review of the Immune System - p. 466 38. 55 : Childhood Immunization - p. 475 39. 56 : Antihistamines - p. 487 40. 57 : Cyclooxygenase Inhibitors: Nonsteroidal Antiinflammatory Drugs and Acetaminophen - p. 492 41. 58 : Glucocorticoids in Nonendocrine Disorders - p. 503 42. 59 : Drug Therapy of Rheumatoid Arthritis - p. 511 43. 60 : Drug Therapy for Gout - p. 527 44. 61 : Drugs Affecting Calcium Levels and Bone Mineralization - p. 536 45. 62 : Drugs for Asthma and Chronic Obstructive Pulmonary Disease - p. 555 46. 63 : Drugs for Allergic Rhinitis, Cough, and Colds - p. 579 47. 64 : Drugs for Peptic Ulcer Disease - p. 587 48. 65 : Laxatives - p. 597 49. 66 : Other Gastrointestinal Drugs - p. 604 50. 67 : Vitamins - p. 615 51. 68 : Drugs for Weight Loss - p. 626 52. 69 : Complementary and Alternative Therapy - p. 634 53. 70 : Basic Principles of Antimicrobial Therapy - p. 649 54. 71 : Drugs That Weaken the Bacterial Cell Wall I: Penicillins - p. 661 55. 72 : Drugs That Weaken the Bacterial Cell Wall II: Other Drugs - p. 668 56. 73 : Bacteriostatic Inhibitors of Protein Synthesis - p. 675 57. 74 : Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis - p. 682 58. 75 : Sulfonamide Antibiotics and Trimethoprim - p. 687 59. 76 : Drug Therapy of Urinary Tract Infections - p. 694 60. 77 : Drug Therapy for Tuberculosis - p. 699 61. 78 : Miscellaneous Antibacterial Drugs - p. 710 62. 79 : Antifungal Agents - p. 714 63. 80 : Antiviral Agents I: Drugs for Non-HIV Viral Infections - p. 722 64. 81 : Antiviral Agents II: Drugs for HIV Infection - p. 743 65. 82 : Drug Therapy for Sexually Transmitted Diseases - p. 762 66. 83 : Anthelmintics - p. 770 67. 84 : Introduction to Immunomodulators - p. 775 68. 85 : Anticancer Drugs for the Nonspecialist - p. 780 69. 86 : Pain Management in Patients With Cancer - p. 813 70. 87 : Drugs for the Eye - p. 821 71. 88 : Drugs for the Skin - p. 833 72. 89 : Drugs for the Ear - p. 848 73. 90 : Agents Affecting the Volume and Ion Content of Body Fluids - p. 855 74. 91 : Management of ST-Segment Elevation Myocardial Infarction - p. 860 75. 92 : Drugs for Acute Care - p. 865 76. Appendix A : Canadian Drug Information - p. 875 77. Index - p. 879

Indice
Autores
Muestra
Ficha Técnica